Position in IDXX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$777,025
-$237,748 QoQ
Shares Held
1,476
-18.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#683
of 1,286 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 36%
Shared 0%
None 64%
Common Shares in IDXX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Pallas Capital Advisors LLC holds $18,791,753 across 11 Diagnostics & Research names. IDXX ranks #7 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
10,365 | $5,196,596 | |
| 2 | ILMN |
Illumina, Inc.
|
25,513 | $4,485,950 | |
| 3 | NTRA |
Natera, Inc.
|
9,853 | $2,674,596 | |
| 4 | A |
Agilent Technologies, Inc.
|
12,937 | $1,718,421 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
8,032 | $1,551,943 | |
| 6 | MEDP |
Medpace Holdings, Inc.
|
2,142 | $1,134,381 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
This page
|
1,476 | $777,025 | |
| 8 | DHR |
Danaher Corp /De/
|
3,367 | $641,346 |
All Filings in IDXX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $777,025 | 1,476 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,014,773 | 1,806 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $1,392,298 | 2,058 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $1,444,530 | 2,261 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $1,251,817 | 2,334 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $467,404 | 1,113 | Shares | Sole | 2025-04-14 | |
| No filing history on record for this holder in this stock. | ||||||